Category
106 articles — page 6 of 9
April 13, 2026
Vitiligo patients need daily sunscreen, and the guidance changes during pregnancy. Here is which sunscreen ingredients are considered safe in pregnancy, which to avoid, and the practical recommendations for protecting depigmented skin while pregnant.
April 13, 2026
Not all vitiligo patches respond the same way. The face responds well to most treatments. The hands and feet are notoriously resistant. Here is a body-area breakdown of what works where, why location matters, and how to set realistic expectations for each site.
April 13, 2026
A patient-friendly side-by-side of every major vitiligo treatment — how they work, what they cost, who they suit, and what the evidence actually says about each one.
March 29, 2026
Vitiligo patients show consistent gut microbiome differences compared to healthy controls. Whether fixing that gap changes outcomes is less clear. Here is the honest picture.
March 29, 2026
Opzelura is the first FDA-approved topical treatment specifically for vitiligo. Here is everything patients need to know: how it works, who responds, realistic timelines, cost, and what to do if insurance denies it.
March 29, 2026
Opzelura is frequently denied on first submission. Most denials can be successfully appealed. Here is the exact process, what your dermatologist needs to write, and the argument that works.
March 29, 2026
AbbVie submitted upadacitinib for FDA and EMA approval in February 2026. It is oral, systemic, and could address body vitiligo where topical treatments fall short.
March 19, 2026
Ayurveda offers several herbs and approaches used for vitiligo, ranging from well-researched (bakuchi/psoralen) to unsupported. This is a careful evidence-based review of each major Ayurvedic approach, including real risks with DIY bakuchi use.
March 17, 2026
Skin discoloration has many causes — vitiligo, tinea versicolor, post-inflammatory changes. Here is how to tell them apart and what treatments apply.
March 15, 2026
Piperine, the active compound in black pepper, has legitimate biological interest for vitiligo — researchers have studied it for effects on melanocyte activity and pigmentation. Here is what the research actually shows, what it does not show, and why topical use is riskier than most articles admit.
March 13, 2026
Homeopathy is widely marketed for vitiligo, especially in some regions. Here is an honest assessment of what the evidence shows, what the real risks are, and what tends to work better for the same goals.
March 11, 2026
Vitiligo in children is common and treatable. Opzelura is now approved for ages 12+. Here is what parents need to know about diagnosis, treatment options, school, and the emotional picture.
